Double-blind trial of flurbiprofen and phenylbutazone in acute gouty arthritis. 1985

R C Butler, and D H Goddard, and C S Higgens, and P Hollingworth, and C T Pease, and M A Stodell, and J T Scott

Flurbiprofen has been compared with phenylbutazone in a double-blind study involving 33 patients with acute gout. Patients received either flurbiprofen 400 mg daily for 48 h followed by 200 mg daily, or phenylbutazone 800 mg daily for 48 h followed by 400 mg daily. The drugs were of comparable efficacy, while side-effects were uncommon and relatively mild. Flurbiprofen appears to be a satisfactory alternative to phenylbutazone in the management of acute gouty arthritis.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010653 Phenylbutazone A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS. Diphenylbutazone,Fenilbutazon,Butacote,Butadion,Butadione,Butapirazol,Butapyrazole,Butazolidin
D011422 Propionates Derivatives of propionic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxyethane structure. Propanoate,Propanoic Acid,Propionate,Propanoates,Propanoic Acid Derivatives,Propanoic Acids,Propionic Acid Derivatives,Propionic Acids,Acid, Propanoic,Acids, Propanoic,Acids, Propionic,Derivatives, Propanoic Acid,Derivatives, Propionic Acid
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005480 Flurbiprofen An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE. 2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic Acid,Ansaid,Apo-Flurbiprofen,BTS-18322,Cebutid,Dobrofen,E-7869,Flubiprofen,Flugalin,Flurbiprofen Sodium,Fluriproben,Froben,Froben SR,Neo Artrol,Novo-Flurprofen,Nu-Flurbiprofen,Ocufen,Ocuflur,Strefen,ratio-Flurbiprofen,Apo Flurbiprofen,BTS 18322,BTS18322,E 7869,E7869,Novo Flurprofen,Nu Flurbiprofen,ratio Flurbiprofen
D006073 Gout Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi. Gouts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R C Butler, and D H Goddard, and C S Higgens, and P Hollingworth, and C T Pease, and M A Stodell, and J T Scott
September 1976, Wiener klinische Wochenschrift,
R C Butler, and D H Goddard, and C S Higgens, and P Hollingworth, and C T Pease, and M A Stodell, and J T Scott
April 1979, Arthritis and rheumatism,
R C Butler, and D H Goddard, and C S Higgens, and P Hollingworth, and C T Pease, and M A Stodell, and J T Scott
May 1979, The Journal of the Association of Physicians of India,
R C Butler, and D H Goddard, and C S Higgens, and P Hollingworth, and C T Pease, and M A Stodell, and J T Scott
June 2002, BMJ (Clinical research ed.),
R C Butler, and D H Goddard, and C S Higgens, and P Hollingworth, and C T Pease, and M A Stodell, and J T Scott
January 1978, Scandinavian journal of rheumatology. Supplement,
R C Butler, and D H Goddard, and C S Higgens, and P Hollingworth, and C T Pease, and M A Stodell, and J T Scott
January 1980, Current medical research and opinion,
R C Butler, and D H Goddard, and C S Higgens, and P Hollingworth, and C T Pease, and M A Stodell, and J T Scott
August 1956, The American journal of medicine,
R C Butler, and D H Goddard, and C S Higgens, and P Hollingworth, and C T Pease, and M A Stodell, and J T Scott
December 1954, Annals of the rheumatic diseases,
R C Butler, and D H Goddard, and C S Higgens, and P Hollingworth, and C T Pease, and M A Stodell, and J T Scott
January 1979, Current medical research and opinion,
R C Butler, and D H Goddard, and C S Higgens, and P Hollingworth, and C T Pease, and M A Stodell, and J T Scott
January 1977, Current medical research and opinion,
Copied contents to your clipboard!